Baudax Bio Acquires TeraImmune, Inc.

TeraImmune, an Advanced Treg Research Company, headed by Yong Chan Kim, Ph D, brings an approved Treg IND to the Strong Development team from Baudax

Baudax Bio CEO Gerri Henwood to Serve as CEO of Combined Entity

Read more at globenewswire.com